Cite
Jensen TJ, Goodman AM, Ellison CK, et al. Genome-wide Sequencing of Cell-free DNA Enables Detection of Copy-number Alterations in Patients with Cancer Where Tissue Biopsy is Not Feasible. Mol Cancer Ther. 2021;20(11):2274-2279doi: 10.1158/1535-7163.MCT-20-1066.
Jensen, T. J., Goodman, A. M., Ellison, C. K., Holden, K. A., Kato, S., Kim, L., Daniels, G. A., Fitzgerald, K., McCarthy, E., Nakashe, P., Mazloom, A. R., Almasri, E., McLennan, G., Grosu, D. S., Eisenberg, M., & Kurzrock, R. (2021). Genome-wide Sequencing of Cell-free DNA Enables Detection of Copy-number Alterations in Patients with Cancer Where Tissue Biopsy is Not Feasible. Molecular cancer therapeutics, 20(11), 2274-2279. https://doi.org/10.1158/1535-7163.MCT-20-1066
Jensen, Taylor J, et al. "Genome-wide Sequencing of Cell-free DNA Enables Detection of Copy-number Alterations in Patients with Cancer Where Tissue Biopsy is Not Feasible." Molecular cancer therapeutics vol. 20,11 (2021): 2274-2279. doi: https://doi.org/10.1158/1535-7163.MCT-20-1066
Jensen TJ, Goodman AM, Ellison CK, Holden KA, Kato S, Kim L, Daniels GA, Fitzgerald K, McCarthy E, Nakashe P, Mazloom AR, Almasri E, McLennan G, Grosu DS, Eisenberg M, Kurzrock R. Genome-wide Sequencing of Cell-free DNA Enables Detection of Copy-number Alterations in Patients with Cancer Where Tissue Biopsy is Not Feasible. Mol Cancer Ther. 2021 Nov;20(11):2274-2279. doi: 10.1158/1535-7163.MCT-20-1066. Epub 2021 Aug 31. PMID: 34465593.
Copy
Download .nbib